Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ruhstaller, Thomas"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 118
Tytuł:
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Autorzy:
Tausch, ChristophAff1, Aff2
Däster, KavithaAff1, IDs10549023069999_cor2
Hayoz, Stefanie
Matrai, ZoltanAff4, Aff5
Fitzal, FlorianAff6, Aff7
Henke, GuidoAff8, Aff9
Zwahlen, Daniel R.
Gruber, Günther
Zimmermann, FrankAff12, Aff13
Andreozzi, MariacarlaAff12, Aff14
Goldschmidt, MaiteAff12, Aff14
Schulz, AlexandraAff12, Aff15
Maggi, NadiaAff12, Aff14
Saccilotto, RamonAff12, Aff15
Heidinger, MartinAff12, Aff14
Mueller, AndreasAff3, Aff16
Tampaki, Ekaterini Christina
Bjelic-Radisic, Vesna
Sávolt, Ákos
Smanykó, Viktor
Hagen, Daniela
Müller, Dieter J.
Gnant, MichaelAff7, Aff21
Loibl, Sibylle
Markellou, Pagona
Bekes, Inga
Egle, DanielAff7, Aff24
Ruhstaller, ThomasAff12, Aff25
Muenst, SimoneAff12, Aff26
Kuemmel, SherkoAff27, Aff28
Vrieling, Conny
Satler, Rok
Becciolini, Charles
Bucher, Susanne
Kurzeder, ChristianAff12, Aff14
Simonson, Colin
Fehr, Peter M.
Gabriel, Natalie
Maráz, Robert
Sarlos, Dimitri
Dedes, Konstantin J.
Leo, Cornelia
Berclaz, Gilles
Fansa, Hisham
Hager, ChristopherAff7, Aff41
Reisenberger, KlausAff7, Aff42
Singer, Christian F.Aff7, Aff43
Montagna, Giacomo
Reitsamer, RolandAff7, Aff45
Winkler, Jelena
Lam, Giang Thanh
Fehr, Mathias K.
Naydina, Tatiana
Kohlik, Magdalena
Clerc, Karine
Ostapenko, Valerijus
Lelièvre, Loïc
Heil, Jörg
Knauer, Michael
Weber, Walter PaulAff12, Aff14
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 201(2):215-225
Czasopismo naukowe
Szczegóły
Tytuł:
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Autorzy:
Panje, Cédric (AUTHOR)
Hayoz, Stefanie (AUTHOR)
Eisterer, Wolfgang (AUTHOR)
Hess, Viviane (AUTHOR)
Thuss-Patience, Peter (AUTHOR)
Schacher, Sabina (AUTHOR)
Dürr, Donat (AUTHOR)
Wagner, Anna Dorothea (AUTHOR)
Girschikofsky, Michael (AUTHOR)
Eboulet, Eric (AUTHOR)
Stahl, Michael (AUTHOR)
Ruhstaller, Thomas (AUTHOR) thomas.ruhstaller@tbz-ost.ch
Pokaż więcej
Źródło:
European Journal of Cancer. Dec2022, Vol. 177, p186-193. 8p.
Czasopismo naukowe
Szczegóły
Tytuł:
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Autorzy:
Weber, Walter P.
Matrai, Zoltan
Hayoz, Stefanie
Tausch, Christoph
Henke, Guido
Zwahlen, Daniel R.
Gruber, Günther
Zimmermann, Frank
Seiler, Stefanie
Maddox, Charlotte
Ruhstaller, Thomas
Muenst, Simone
Ackerknecht, Markus
Kuemmel, Sherko
Bjelic-Radisic, Vesna
Kurzeder, Christian
Újhelyi, Mihály
Vrieling, Conny
Satler, Rok
Meyer, Inna
Pokaż więcej
Temat:
AXILLARY lymph node dissection
BREAST cancer
SENTINEL lymph nodes
NEOADJUVANT chemotherapy
Źródło:
Breast; Dec2021, Vol. 60, p98-110, 13p
Czasopismo naukowe
Szczegóły
Tytuł:
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.
Autorzy:
Onesti, Concetta Elisa (AUTHOR)
Tagliamento, Marco (AUTHOR)
Curigliano, Giuseppe (AUTHOR)
Harbeck, Nadia (AUTHOR)
Bartsch, Rupert (AUTHOR)
Wildiers, Hans (AUTHOR)
Tjan-Heijnen, Vivianne (AUTHOR)
Martin, Miguel (AUTHOR)
Rottey, Sylvie (AUTHOR)
Generali, Daniele (AUTHOR)
Campone, Mario (AUTHOR)
Cristofanilli, Massimo (AUTHOR)
Pusztai, Lajos (AUTHOR)
Peeters, Marc (AUTHOR)
Berchem, Guy (AUTHOR)
Cortes, Javier (AUTHOR)
Ruhstaller, Thomas (AUTHOR)
Ciruelos, Eva (AUTHOR)
Rugo, Hope S. (AUTHOR)
Jerusalem, Guy (AUTHOR)
Pokaż więcej
Źródło:
JCO Global Oncology. 2/2/2021, Vol. 7, p162-172. 11p.
Czasopismo naukowe
Szczegóły
Tytuł:
Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial.
Autorzy:
Meier-Girard D; Institute of Complementary and Integrative Medicine, University of Bern, Fabrikstrasse 8, 3012, Bern, Switzerland. .
Ribi K; International Breast Cancer Study Group, Coordinating Center, Bern, Switzerland.
Gerstenberg G; Institute of Complementary and Integrative Medicine, University of Bern, Fabrikstrasse 8, 3012, Bern, Switzerland.
Ruhstaller T; Breast Center of Eastern Switzerland, St. Gallen, Switzerland.
Wolf U; Institute of Complementary and Integrative Medicine, University of Bern, Fabrikstrasse 8, 3012, Bern, Switzerland.
Pokaż więcej
Źródło:
Trials [Trials] 2020 Jul 06; Vol. 21 (1), pp. 612. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji:
Clinical Trial Protocol; Comparative Study; Journal Article
MeSH Terms:
Mindfulness*
Quality of Life*
Breast Neoplasms/*therapy
Exercise Therapy/*methods
Fatigue/*rehabilitation
Breast Neoplasms/complications ; Breast Neoplasms/pathology ; Complementary Therapies ; Fatigue/etiology ; Fatigue/psychology ; Humans ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Switzerland ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution's Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer.
Autorzy:
Maranta, Angela Fischer
Broder, Simon
Fritzsche, Constanze
Knauer, Michael
Thürlimann, Beat
Jochum, Wolfram
Ruhstaller, Thomas
Pokaż więcej
Temat:
BREAST cancer
CANCER patients
DISTRIBUTION (Probability theory)
TUMOR grading
DEFINITIONS
Źródło:
Breast; Jun2020, Vol. 51, p120-126, 7p
Terminy geograficzne:
MILAN (Italy)
Czasopismo naukowe
Szczegóły
Tytuł:
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99.
Autorzy:
Eppenberger-Castori S; University Hospital Basel, Institute of Human Genetic and Pathology, Schönbeinstrasse 40, CH-4031, Basel, Switzerland. .
Klingbiel D; SAKK Swiss Group for Clinical Cancer Research Coordinating Centre, Bern, Switzerland.; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Ruhstaller T; Brustzentrum Ostschweiz and University of Basel, St. Gallen, Switzerland.; University of Basel, Basel, Switzerland.
Dietrich D; SAKK Swiss Group for Clinical Cancer Research Coordinating Centre, Bern, Switzerland.
Rufle DA; University Hospital Basel, Institute of Human Genetic and Pathology, Schönbeinstrasse 40, CH-4031, Basel, Switzerland.
Rothgiesser K; SAKK Swiss Group for Clinical Cancer Research Coordinating Centre, Bern, Switzerland.
Pagani O; Breast Unit and Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Lugano, Viganello, Switzerland.
Thürlimann B; University of Basel, Basel, Switzerland.; Breast Centre St, Gallen, Switzerland.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Feb 11; Vol. 20 (1), pp. 114. Date of Electronic Publication: 2020 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Protein Domains*
Breast Neoplasms/*blood
Breast Neoplasms/*mortality
Receptor, ErbB-2/*blood
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/diagnosis ; Breast Neoplasms/drug therapy ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Molecular Targeted Therapy ; Prognosis ; Receptor, ErbB-2/antagonists & inhibitors ; Receptor, ErbB-2/chemistry ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort.
Autorzy:
Varga Z; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. .
Li Q; SAKK Coordinating Center, Bern, Switzerland.
Jochum W; Institute of Pathology, Cantonal Hospital, Gt. Gallen, Switzerland.
Perriard U; The Cantonal Institute of Pathology, Locarno, Switzerland.
Rau T; Institute of Pathology, University Hospital Bern, Bern, Switzerland.
Tille JC; Division of Clinical Pathology, University Hospital Geneva, Geneva, Switzerland.
Hawle H; SAKK Coordinating Center, Bern, Switzerland.
Klingbiel D; SAKK Coordinating Center, Bern, Switzerland.
Thuerlimann B; Breast Center, St. Gallen, Cantonal Hospital, St. Gallen, Switzerland.
Ruhstaller T; Breast Center, St. Gallen, Cantonal Hospital, St. Gallen, Switzerland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Sep 19; Vol. 9 (1), pp. 13534. Date of Electronic Publication: 2019 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*classification
Breast Neoplasms/*metabolism
Ki-67 Antigen/*metabolism
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Pharmacological/analysis ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant/methods ; Cohort Studies ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry/methods ; Ki-67 Antigen/immunology ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Receptor, ErbB-2 ; Receptors, Estrogen ; Receptors, Progesterone ; Reproducibility of Results ; Switzerland
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Autorzy:
Panje CM; Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland. .
Höng L; Department of Radiation Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
Hayoz S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Baracos VE; Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Herrmann E; Department of Radiation Oncology, Inselspital Bern, Bern, Switzerland.
Garcia Schüler H; University Hospital Zurich, Zurich, Switzerland.
Meier UR; Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Henke G; Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Schacher S; Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Hawle H; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Gérard MA; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Ruhstaller T; Department of Medical Oncology and Hematology, Kantonsspital St. Gallen and University of Basel, Basel, Switzerland.
Plasswilm L; Department of Radiation Oncology, Kantonsspital St Gallen, St Gallen and University of Bern, Bern, Switzerland.
Pokaż więcej
Corporate Authors:
Swiss Group for Clinical Cancer Research (SAKK)
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2019 Sep 11; Vol. 14 (1), pp. 166. Date of Electronic Publication: 2019 Sep 11.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Adenocarcinoma/*therapy
Chemoradiotherapy/*adverse effects
Esophageal Neoplasms/*therapy
Esophageal Squamous Cell Carcinoma/*therapy
Muscle, Skeletal/*pathology
Neoadjuvant Therapy/*adverse effects
Sarcopenia/*pathology
Adenocarcinoma/pathology ; Adult ; Aged ; Combined Modality Therapy ; Cross-Sectional Studies ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma/pathology ; Esophagectomy/adverse effects ; Female ; Humans ; Image Processing, Computer-Assisted/methods ; Male ; Middle Aged ; Muscle, Skeletal/diagnostic imaging ; Prognosis ; Sarcopenia/diagnostic imaging ; Sarcopenia/etiology ; Survival Rate ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
Autorzy:
Schmid S; Breast Center St. Gallen, Kantonsspital, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland. .
Klingbiel D; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland.
Aebi S; Cancer Center, Lucerne Cantonal Hospital, Lucerne and University of Bern, Bern, Switzerland.
Goldhirsch A; Department of Oncology, European Institute of Oncology (IEO), Milan, Italy.
Mamot C; Department of Oncology and Haematology, Kantonsspital Aarau, Aarau, Switzerland.
Munzone E; Division of Medical Senology, European Institute of Oncology (IEO), Milan, Italy.
Nolè F; Department of Oncology, European Institute of Oncology (IEO), Milan, Italy.
Oehlschlegel C; Formerly Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Pagani O; Breast Unit and Institute of Oncology of Southern Switzerland, Ospedale Regionale Bellinzona e Valli and Geneva University Hospitals, Bellinzona, Switzerland.
Pestalozzi B; Department of Oncology, University Hospital Zürich, Zürich, Switzerland.
Rochlitz C; Department of Oncology, University Hospital Basel, Basel, Switzerland.
Thürlimann B; Breast Center St. Gallen, Kantonsspital, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.
von Moos R; Department of Oncology, Kantonsspital Graubünden, Chur, Switzerland.
Weder P; Breast Center St. Gallen, Kantonsspital, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.
Zaman K; Breast Center CHUV, Department of Oncology, University Hospital CHUV, Lausanne, Switzerland.
Ruhstaller T; Breast Center St. Gallen, Kantonsspital, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.; Medizinische Fakultät, Universität Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Sep 10; Vol. 19 (1), pp. 902. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji:
Clinical Trial, Phase III; Journal Article
MeSH Terms:
Receptor, ErbB-2*
Breast Neoplasms/*drug therapy
Trastuzumab/*therapeutic use
Aged ; Antineoplastic Agents, Immunological/therapeutic use ; Breast Neoplasms/metabolism ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores.
Autorzy:
Gargiulo, Piera
Dietrich, Daniel
Herrmann, Richard
Bodoky, György
Ruhstaller, Thomas
Scheithauer, Werner
Glimelius, Bengt
Berardi, Simona
Pignata, Sandro
Brauchli, Peter
Pokaż więcej
Źródło:
Therapeutic Advances in Medical Oncology; 1/2/2019, Vol. 11, p1-13, 13p
Czasopismo naukowe
Szczegóły
Tytuł:
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Autorzy:
Henke, Guido
Knauer, Michael
Ribi, Karin
Hayoz, Stefanie
Gérard, Marie-Aline
Ruhstaller, Thomas
Zwahlen, Daniel R
Muenst, Simone
Ackerknecht, Markus
Hawle, Hanne
Fitzal, Florian
Gnant, Michael
Mátrai, Zoltan
Ballardini, Bettina
Gyr, Andreas
Kurzeder, Christian
Weber, Walter P
Pokaż więcej
Źródło:
Trials. 12/4/2018, Vol. 19 Issue 1, p667-667. 1p.
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 118

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies